Acessibilidade / Reportar erro

Incidence of nontraumatic musculoskeletal injuries in handball athletes

Abstracts

Competitive athletes often present musculoskeletal injuries, some of these nontraumatic. Usually these injuries are attributed to mechanical factors. The present study aimed to investigate a group of handball players and check a possible action of immune-inflammatory and hormonal factors in the genesis of these lesions. Laboratory parameters were studied measuring in the plasma the concentration of plasma hormones and neurotransmitters, and production "in vitro" of cytokines and prostaglandin E2. The results indicate that in 29% of the athletes included in the study the occurrence of nontraumatic musculoskeletal injuries was observed. In this group there was an increased production of pro-inflammatory cytokines assayed in the supernatant of culture of peripheral blood cells with increased concentrations of IL-1, IL-2, TNF-α and IFN-α, as well of prostaglandin E2.

cytokines; sports; nontraumatic injuries


O atleta competitivo muitas vezes apresenta lesões musculoesqueléticas, algumas de natureza não traumática. Habitualmente, tais lesões são atribuídas a fatores mecânicos. O presente estudo teve como objetivo estudar um grupo de atletas de handebol e verificar uma possível ação de fatores imune-inflamatórios e hormonais na gênese destas lesões. Procedeu-se à avaliação dos parâmetros laboratoriais, dosando-se a concentração plasmática de hormônios e neurotransmissores e a produção in vitro de citocinas e prostaglandina E2. Os resultados permitem afirmar que em 29% dos atletas estudados foi possível constatar a ocorrência de lesões musculoesqueléticas não traumáticas, que puderam ser relacionadas com o aumento da produção de citocinas pró-inflamatórias, com elevação das concentrações de IL-1, IL-2, TNF-α e IFN-α. Nesta mesma cultura foi possível demonstrar aumento da concentração de prostaglandina E2.

citocinas; esporte; lesão sem trauma


ORIGINAL ARTICLE

LOCOMOTOR APPARATUS IN EXERCISE AND SPORTS

Incidence of nontraumatic musculoskeletal injuries in handball athletes

Matheus Cavalcante de SáI; Angélica Begatti VictorinoII; Mauro Walter VaisbergI

IDepartment of Otorhinolaryngology and Head and Neck Surgery of the Federal University of São Paulo - São Paulo, SP

IIDepartment of Microbiology and Immunology of the Federal University of São Paulo - São Paulo, SP

Correspondence

ABSTRACT

Competitive athletes often present musculoskeletal injuries, some of these nontraumatic. Usually these injuries are attributed to mechanical factors. The present study aimed to investigate a group of handball players and check a possible action of immune-inflammatory and hormonal factors in the genesis of these lesions. Laboratory parameters were studied measuring in the plasma the concentration of plasma hormones and neurotransmitters, and production "in vitro" of cytokines and prostaglandin E2. The results indicate that in 29% of the athletes included in the study the occurrence of nontraumatic musculoskeletal injuries was observed. In this group there was an increased production of pro-inflammatory cytokines assayed in the supernatant of culture of peripheral blood cells with increased concentrations of IL-1, IL-2, TNF-α and IFN-α, as well of prostaglandin E2.

Keywords: cytokines, sports, nontraumatic injuries.

INTRODUCTION

Overload of the musculoskeletal system is intrinsic to sports practice and within physiological thersholds, there is a compensation. However, excessive or miscompensated overload hampers a suitable rebalance process, leading to disorganization of the system causing injuries1. These injuries are classified as nontraumatic or injuries by excessive use (overuse syndromes) which, when causing microtrauma by the application of shear stress will be compensated until this additional stress results in injury2. The decreased contractibility of fatigued muscles limits their capacity to absorb shock and stress1. Training volume is also mentioned as cause of this kind of injury 2, being suggested that in runners there is a direct relation between mileage and onset of this kind of trauma.

Hill et al.3, in a study in which they followed female softball players for a two-year period, showed that more than 70% of the athletes presented musculoskeletal injuries and that 70% of these were related to injury mechanisms by overtraining, demonstrating the importance of this mechanism. Other factors were mentioned by Ekstrand et al.4, who, when following the national Sweden soccer senior team for seven years, found out that injury incidence was five times higher after competitive matches when compared with training. It has also been demonstrated that the number of injuries significantly increased when the team lost the games, suggesting that non-mechanical factors could be involved in the genesis of nontraumatic injuries.

Small5 observed that 80% of the complaints reported in sports medicine clinics referred to pain and that in the absence of trauma, fibromyalgia6 was one of the main causes associated to pain triggering. Cramer7 also suggests that athletes can present a situation similar to the chronic fatigue syndrome and that these can be associated with the onset of musculoskeletal injury. This author highlights the need to distance viral pathology, stress, depression or exposure to environmental toxin8. When observing athletes, Vaisberg et al.9 observed that complaints of muscular pain occur in high proportion in track and field and Olympic gymnastics practitioners, as well as the need for winning as an important factor related to the development of anguish which was clearly associated with pain complaint10.

Ader and Cohen11 and Besedovsky et al.12, in the 1970's, experimentally demonstrated the close functional relation between the neuroendocrine and immunological systems, which enabled an integrated view of the homeostatic mechanisms of the human body, providing physiopathological grounding which explain as alterations of psychological nature such as stress, anxiety and depression present association with greater incidence of sports injuries without trauma.

Recently, many studies in experimental models and humans demonstrated that psychological stress stimulates the production of pro-inflammatory cytokines17-19. Black20, in extensive review on the topic, shows that, in response to the psychological stress, an inflammatory process occurs by the release by sensory nerves of neuropeptides. The lipids release which occurs in response to stress is an additional factor for activation of macrophages and release of cytokines21. Therefore, the activation of the inflammatory process by the central nervous system helps to understand how a psychological process may cause through mediation of pro-inflammatory cytokines and oxygen and nitrogen intermediate reactives muscle, tendon and bursa injuries, in the absence of physical trauma22.

The present study had the aim to verify the incidence of musculoskeletal injury without trauma in handball athletes relating its incidence to the production of cytokines and neurotransmitters.

METHODOLOGY

Sample

The experimental protocol was approved by the Ethics Committee of the Institute of Biomedical Sciences of the University of São Paulo. All subjects were informed about the aims and risks of the study, and their informed consent was obtained in a free and clear way, according to resolution 196/96 from the National Health Board.

59 handball athletes, mean age of 31.9 ± 4.2 years, engaged in regular competitions and not presenting symptoms of acute infection or trauma were studied in the present study. The blood samples (20ml) were collected from an antecubital vein with the individuals at sitting position, before the training session (09:00h a.m.), after a minimum period of eight hours at fasting and 20 hours from the last training session, for analysis of cytokines production by mononuclear cells of the peripheral blood, and determination of the hormone and neurotransmitter concentration.

Clinical Assessment

Evaluation of injury without trauma occurred with analysis of the athletes' medical records, being considered as injury without trauma patients those who visited the infirmary at least twice a month for six consecutive months, with complaint of injury in the soft tissues (muscles, tendons and bursas), without apparent trauma. Based on that evaluation, the athletes were divided in two groups: injury without trauma - repetitive stress injury (RSI) and athletes without repetitive injury (WI). As supporting instrument for evaluation of muscular pain, the athletes were submitted to clinical assessment following criteria by the American College of Rheumatology6, validated for the Brazilian population23, using the discomfort criterion through application of force of 4kg/cm2 on the spot proposed as fibromyalgia triggering-spots, a condition associated with chronic pain. Such instrument was used due to report by Small, relating chronic pain of the athlete with fibromyalgia5. The clinical evaluation was performed by an experienced rheumatologist.

Hormone and neurotransmitter plasma concentration

Each 10ml blood sample was transferred to a glass tube containing 5ml of heparin (500IU/ml). The tubes were kept in ice until centrifugation at 960xg per 8min. The plasma concentration of cortisol, prolactin and growth hormone (GH) was measured by radioimmunoassay (commercial kit AIA-PACK, Medics Tosoh, Inc.). Adrenalin, dopamine, noradrenalin and L-dopa plasma levels were determined by high-performance liquid chromatography (HPLC), with electrochemical detection24. The chromatographic system (Shimadzu) was composed of a LC-10AD pump vp isocratic HPLC, a C18, RP 18 Brownlee 4.6 x 250mm of spherical 5ml, a steel column (Millipore Co), and an electrochemical detector L-ECD-6A operated in DC mode, controlled by the Shimadzu CLASS-VP software through a system interface module. The samples were eluded with a mixture: 20mM dibasic sodium; 20mM phosphate, in citric acid of pH 2.64 and 10% of methanol, Na2EDTA 0.12mM and 566mg/L of heptane sulphonic acid.

Determination of cytokines production

The total blood cells were plated (1.0 x 106 cells/ml) in plastic Petri dishes RPMI 1624 (medium enriched with glutamine 02mM, streptomycin 2.5mg/ml and penicillin 2.5UI/ml). After 48h, the concentrations of the IL-1, IL-2, IL-4, IL-6 cytokines, the interferon alpha (IFN-α) and the tumor necrosis factor alpha (TNF-α) were measured in the supernatant using ELISA kits (Quantikine®, R&D Systems, Inc). The prostaglandin E2 (PGE2) was measured using an Amersham Pharmacia Biotech kit (BiotrakTM). Total blood culture without stimulus was the choice to preserve the athletes' conditions at the collection time.

STATISTICAL ANALYSIS

Data were considered parametric after a K-S test (α = 5%), and compared using Student's t test and Welch correlation, whenever necessary. Minimal significance level of p < 0.05 was chosen for all statistical comparisons. Data are presented as mean ± SEM.

RESULTS

The evaluation of the medical records of the athletes indicated that 29% out of the 59 athletes presented repetitive strain injury without trauma and chronic muscular pain (group RSI). Additionally, it was observed that the group of athletes with highest incidence of musculoskeletal injuries without trauma presented higher number of painful spots to the clinical assessment (figure 1), with median of painful spots of 09, while athletes who did not present muscular repetitive strain injury presented median of five positive points.


Concerning the plasma cortisol, prolactin, GH, adrenalin, noradrenalin, dopamine, L-dopa and creatinine concentrations, there was no significant difference between groups (table 1).

Increase in production of IL-1, IL-2, TNF-α, IFN-α and PGE2 was observed on the supernatant of cultures obtained from athletes of the group fibromyalgia, compared with the control group. The IL-4 and IL-6 concentration in the supernatant of the cultures were not different between groups (table 2).

DISCUSSION

It could be observed that an expressive number of athletes presented muscular repetitive strain injury (RSI) without trauma. It was associated with well-defined laboratory alteration, with increase of pro-inflammatory cytokines an activation of the immune-inflammatory response. Such finding offers us the opportunity to build a rich information scenario which can have great value, both in the diagnosis and prevention of nontraumatic injury of athletes.

The athletes included in this study were in their normal sports practice and did not present any apparent pathology. However, those who presented RSI presented laboratory alterations compatible with an inflammatory episode, evidenced by increase of pro-inflammatory cytokines and activation of immune system, proved by the increase of IL-2. Recently, Black20, when discussing the mechanisms associated with neurogenic inflammation, proposed that, in response to the psychological stress or to certain physical stressing agents, an inflammatory process may occur by the release of neuropeptides, with consequent activation of inflammatory cells. It is consistent in the literature the correlation between production of cytokines in response to psychological stressing agents18,19,25.

The stress hormones (cortisol, prolactine and GH), as well as the neurotransmitters, did not present differences between groups, suggesting that even if the athletes are submitted to similar physical stress, it would not be the factor associated with the pathogenesis of the scenario. However, the production of pro-inflammatory cytokines and prostaglandine E2 suggests activation of the immune-inflammatory system, which, regardless of mechanical factor, suggests the activity of another mechanism.

The two groups of athletes presented positive triggering points to the exam; however, the group in which muscular repetitive strain injuries occurred presented median of positive points almost two times higher than the one presented by the group which did not present injuries. The positive and statistically significant correlation demonstrated between the number of positive triggering points and the increase of onset of nontraumatic injuries, suggests that these two findings may have an association.

The report by Small5, relating chronic pain and fibromyalgia as the main complaint in sports medicine infirmaries, although cannot allow the diagnosis of fibromyalgia in these athletes, makes us suppose that there may be a common pathogenic mechanism or that the final manifestation which produces the complaint is similar, so that the use of triggering points could be a simple manner to early detect the risk for muscular injury without trauma in athletes.

CONCLUSION

An exacerbated immune-inflammatory response seems to be the physiopathogenic basis of muscular injury without trauma. Probably, many factors collaborate to this finding and it seems more to be an individual response to stress, be it physical or mental. This finding is important so that the team coaches and doctors are able to help the athletes who present repetitive injuries trying to refer the specialized service. Since the cytokine dosing currently is only available in research laboratories, the evaluation of triggering points by a trained doctor may be a diagnosis instrument which, joined to the athlete's history, is able to diagnose muscular injury without trauma and help taking the necessary measures.

Further studies with other modalities and with a higher number of athletes are necessary to corroborate our findings.

REFERENCES

  • 1. Barry NN, McGuire JL. Overuse syndromes in adult athletes. Rheumatic diseases clinics of North America. [Review]. 1996;22:515-30.
  • 2. Kibler WB. Clinical aspects of muscle injury. Med Sci Sports Exerc. [Case Reports]. 1990;22:450-2.
  • 3. Hill JL, Humphries B, Weidner T, Newton RU. Female collegiate windmill pitchers: influences to injury incidence. J Strength Cond Res. 2004;18:426-31.
  • 4. Ekstrand J, Walden M, Hagglund M. Risk for injury when playing in a national football team. Scandinavian journal of medicine & science in sports. [Comparative Study]. 2004;14:34-8.
  • 5. Small E. Chronic musculoskeletal pain in young athletes. Pediatric clinics of North America. [Review]. 2002;49:655-662, vii.
  • 6. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis and rheumatism. [Comparative Study; Research Support, Non-U.S. Gov't] 1990;33:160-72.
  • 7. Cramer CR. Fibromyalgia and chronic fatigue syndrome: an update for athletic trainers. Journal of athletic training 1998;33:359-61.
  • 8. Komaroff AL, Goldenberg D. The chronic fatigue syndrome: definition, current studies and lessons for fibromyalgia research. The Journal of rheumatology Supplement. [Research Support, Non-U.S. Gov't, Review] 1989;19:23-7.
  • 9. Vaisberg M, Baptista C, Gatti C, Piçarro J, Costa Rosa LF. Fibromialgia: descrição da síndrome em atletas e suas implicações. Rev Bras Med Esporte 2001;7:14-7.
  • 10. Vaisberg T, Reis A, Correia Y, Vaisberg M. Lùsage du "Procédé de Dessins-Histoires avec un theme" dans la recherche clinique et sociele des representations d'enfants sur la pratique dos exercises physiques. XVI Rorschach Society International Congress; Amsterdam, The Netherlands.1999.
  • 11. Ader R, Cohen N. Behaviorally conditioned immunosuppression. Psychosom Med 1975;37:333-40.
  • 12. Besedovsky H, Sorkin E, Felix D, Haas H. Hypothalamic changes during the immune response. Eur J Immunol 1977;7:323-5.
  • 13. Bestwick CS, Maffulli N. Reactive oxygen species and tendinopathy: do they matter? Br J Sports Med 2004;38:672-4.
  • 14. Wang MX, Wei A, Yuan J, Clippe A, Bernard A, Knoops B, et al. Antioxidant enzyme peroxiredoxin 5 is upregulated in degenerative human tendon. Biochemical and biophysical research communications 2001;284:667-73.
  • 15. Meier B, Radeke HH, Selle S, Younes M, Sies H, Resch K, et al. Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumour necrosis factor-alpha. Biochem J 1989;263:539-45.
  • 16. Mackinnon LT. Immunity in athletes. Int J Sports Med 1997;18 Suppl 1:S62-8.
  • 17. Maes M, Scharpe S, Meltzer HY, Bosmans E, Suy E, Calabrese J, et al. Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression. Psychiatry Res 1993;49:11-27.
  • 18. LeMay LG, Vander AJ, Kluger MJ. The effects of psychological stress on plasma interleukin-6 activity in rats. Physiol Behav 1990;47:957-61.
  • 19. Ruzek MC, Miller AH, Opal SM, Pearce BD, Biron CA. Characterization of early cytokine responses and an interleukin (IL)-6-dependent pathway of endogenous glucocorticoid induction during murine cytomegalovirus infection. J Exp Med 1997;185:1185-92.
  • 20. Black PH. Stress and the inflammatory response: a review of neurogenic inflammation. Brain Behav Immun 2002;16:622-53.
  • 21. Seematter G, Binnert C, Martin JL, Tappy L. Relationship between stress, inflammation and metabolism. Curr Opin Clin Nutr Metab Care 2004;7:169-73.
  • 22. Vaisber M. Lesão musculoesquelética sem trauma no esporte. In: Vaisberg M, Mello M, editors. Exercícios na saúde e na doença. 1Ş ed. Barueri: Manole, 2010;303-9.
  • 23. Atallah-Haun M, Ferraz M, Pollak D. Validação dos critérios do Colégio Americano de Reumatologia (1990) para classificação da fibromialgia, em uma população brasileira. Rev Bras Reumatol 1999;39:221-30.
  • 24. Naffah-Mazzacoratti MG, Casarini DE, Fernandes MJS, Cavalheiro EA. Serum catecholamines levels determined by high performance liquid chromatography coupled with eletrochemical detection. Arq Bras endocrinol metabol 1992;36:119-22.
  • 25. Dhabhar FS, Miller AH, McEwen BS, Spencer RL. Stress-induced changes in blood leukocyte distribution. Role of adrenal steroid hormones. J Immunol. [Comparative Study; Research Support, Non-U.S. Gov't] 1996;157:1638-44.
  • Endereço para correspondência:
    Rua dos Otonis, 700, Vila Mariana
    04025-002 - São Paulo, SP, Brasil
    E-mail:
  • Publication Dates

    • Publication in this collection
      14 Feb 2013
    • Date of issue
      Dec 2012
    Sociedade Brasileira de Medicina do Exercício e do Esporte Av. Brigadeiro Luís Antônio, 278, 6º and., 01318-901 São Paulo SP, Tel.: +55 11 3106-7544, Fax: +55 11 3106-8611 - São Paulo - SP - Brazil
    E-mail: atharbme@uol.com.br